Third Harmonic Bio, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
SCHEDULE 13D/A: General Atlantic Completes Divestment of Third Harmonic Bio Stake, Files Final Exit Amendment
Investment firm General Atlantic and its affiliated entities have fully divested their beneficial ownership in Third Harmonic Bio, Inc., marking their complete exit as a reportable shareholder.
SCHEDULE 13D/A: General Atlantic Amends Stake in Third Harmonic Bio, Reaffirming 8.0% Beneficial Ownership
General Atlantic and its affiliated entities have filed an Amendment No. 1 to their Schedule 13D, reaffirming their beneficial ownership of 8.0% of Third Harmonic Bio, Inc.'s common stock and outlining their investment intentions.